diquafosol has been researched along with Eyelid Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Ha, JY; Park, SW; Piao, HL; Sung, MS | 1 |
| Amano, S; Arita, R; Haraguchi, T; Maeda, K; Maeda, S; Suehiro, J; Tokoro, H | 1 |
1 trial(s) available for diquafosol and Eyelid Diseases
| Article | Year |
|---|---|
Topical diquafosol for patients with obstructive meibomian gland dysfunction.
Topics: Aged; Eyelid Diseases; Female; Humans; Image Processing, Computer-Assisted; Male; Meibomian Glands; Ophthalmic Solutions; Polyphosphates; Tears; Treatment Outcome; Uracil Nucleotides | 2013 |
1 other study(ies) available for diquafosol and Eyelid Diseases
| Article | Year |
|---|---|
The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study.
Topics: Eyelid Diseases; Follow-Up Studies; Glaucoma; Humans; Meibomian Glands; Polyphosphates; Prostaglandins, Synthetic; Uracil Nucleotides | 2020 |